# Bioequivalence Study of Two Imiquimod Cream 5%

> **NCT00828568** · PHASE1 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 425 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Imiquimod 5% manufactured by Taro
- **DRUG:** Aldara - Imiquimod 5%
- **DRUG:** Imiquimod Vehicle manufactured by Taro

## Key facts

- **NCT ID:** NCT00828568
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-05
- **Target enrollment:** 425 (ACTUAL)
- **Last updated:** 2014-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828568, "Bioequivalence Study of Two Imiquimod Cream 5%". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00828568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*